Saphetor Sa, A Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Maarten Kempen as Chief Commercial Officer, effective February 1st, 2023. Kempen will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets. “Saphetor has experienced a period of […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina’s Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company’s financial planning and […]
Singapore – Rigaku Asia Pacific PTE LTD (RAPP), the Singapore subsidiary of Rigaku – a global leading manufacturer of X-ray analysis, measurement and testing instruments based in Japan – announced Adam Chong as its new Managing Director and Chief Executive Officer. His primary role will be to expand RAPP’s business, which covers markets in the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced Shane Bohnen has been appointed Senior Vice President, General Counsel effective March 3, 2023. Mr. Bohnen succeeds Brenda Furlow, who will be retiring from the Company after serving as Executive Vice President and General Counsel for the past nine years. Brenda has been and will continue to provide […]
Suresh Pisharody brings strong leadership experience honed at Illumina, Thermo Fisher Scientific, and Guardant Health to lead BioSkryb in its next phase of growth DURHAM, N.C. – BioSkryb Genomics, a pioneer in comprehensive single-cell multi-omic research solutions, has appointed Suresh Pisharody as its new CEO. Mr. Pisharody brings a wealth of experience in building life […]
Suresh Pisharody brings strong leadership experience honed at Illumina, Thermo Fisher Scientific, and Guardant Health to lead BioSkryb in its next phase of growth DURHAM, N.C. – BioSkryb Genomics, a pioneer in comprehensive single-cell multi-omic research solutions, has appointed Suresh Pisharody as its new CEO. Mr. Pisharody brings a wealth of experience in building life […]
The Board of Atlas Antibodies and Nille Klaebel have together agreed that Nille will leave her position as the CEO of Atlas Antibodies Group. Peter Ulvskjold, currently CEO of the division Atlas Antibodies, will assume the role as interim CEO for the Group, as of February 1st. Peter Ulvskjold has been with Atlas Antibodies since […]
Ulrich Krauss charts new course; Oliver Klaeffling set to become managing director Jena – A change is taking place at the top at Analytik Jena. Managing Director Ulrich Krauss has decided to assume other responsibilities outside of Analytik Jena. The Endress+Hauser Group is therefore handing over the management of the subsidiary specializing in laboratory analysis […]
SAN DIEGO — Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — announced the promotion of Shawn Levy, PhD, to Chief Scientific Officer and Senior Vice President of Applications. A world-renowned pioneer in genomics research, Shawn has over 20 years of experience in genomic applications development and technology optimization, along with operational management […]
BOSTON — NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, announced the establishment of Scientific Advisory Board (SAB) to support NanoMosaic’s vision to bring the nanoneedle-powered digital proteomic tool to the life science research and the diagnostic community. Abhishek Chatterjee, Ph.D. joins NanoMosaic SAB. Dr. Abhishek Chatterjee is Professor of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
